|
43
|
116
|
5mqgA |
Crystal structure of crebbp bromodomain complexed with cbp015 |
|
37
|
114
|
5mqeA |
Crystal structure of crebbp bromodomain complexed with cbp006 |
|
57
|
137
|
5mg2A |
Crystal structure of the second bromodomain of human taf1 in complex with bay-299 chemical probe |
|
39
|
117
|
5mqkA |
Crystal structure of crebbp bromodomain complexed with cbp019 |
|
41
|
112
|
5mpkA |
Crystal structure of crebbp bromodomain complexed with dk19 |
|
41
|
106
|
5mkxA |
1.68a structure pcaf bromodomain with 4-chloro-2-methyl-5-(methylamino)pyridazin-3(2h)-one |
|
39
|
118
|
5mpnA |
Crystal structure of crebbp bromodomain complexed with fa26 |
|
38
|
110
|
5mpzA |
Crystal structure of crebbp bromodomain complexed with cbp007 |
|
44
|
115
|
5mmgA |
Crystal structure of crebbp bromodomain complexed with ut07c |
|
39
|
108
|
5ml0A |
Bromodomain of mouse pcaf with (r)-4-chloro-2-methyl-5-((1-methylpiperidin-3-yl)amino)pyridazin-3(2h)-one |
|
41
|
108
|
5lvrA |
Crystal structure of human pcaf bromodomain in complex with compound-e (cpd-e) |
|
41
|
116
|
5lpkA |
Crystal structure of the bromodomain of human ep300 bound to the inhibitor xdm1 |
|
173
|
561
|
5lktA |
Crystal structure of the p300 acetyltransferase catalytic core with butyryl-coenzyme a. |
|
38
|
108
|
5lvqA |
Crystal structure of human pcaf bromodomain in complex with compound-d (cpd-d), n-methyl-2-(tetrahydro-2h-pyran-4-yloxy)benzamide |
|
170
|
560
|
5lkxA |
Crystal structure of the p300 acetyltransferase catalytic core with propionyl-coenzyme a. |
|
2
|
10
|
5l7eB |
Mcr in complex with ligand |
|
164
|
561
|
5lkzA |
Crystal structure of the p300 acetyltransferase catalytic core with crotonyl-coenzyme a. |
|
2
|
10
|
5l7hB |
Mcr in complex with ligand |
|
39
|
116
|
5lpmA |
Crystal structure of the bromodomain of human ep300 bound to the inhibitor xdm3d |
|
166
|
558
|
5lkuA |
Crystal structure of the p300 acetyltransferase catalytic core with coenzyme a. |
|
42
|
114
|
5ktxA |
Crebbp bromodomain in complex with cpd59 ((s)-1-(3-((2-fluoro-4-(1-methyl-1h-pyrazol-4-yl)phenyl)amino)-1-(tetrahydrofuran-3-yl)-6,7-dihydro-1h-pyrazolo[4,3-c]pyridin-5(4h)-yl)ethanone) |
|
37
|
114
|
5ktwA |
Crebbp bromodomain in complex with cpd 44 (3-((5-acetyl-1-(cyclopropylmethyl)-4,5,6,7-tetrahydro-1h-pyrazolo[4,3-c]pyridin-3-yl)amino)-n-isopropylbenzamide) |
|
4
|
19
|
5ji0E |
Ppargamma-rxralpha(s427f) heterodimer in complex with src-1, rosiglitazone, and 9-cis-retanoic acid |
|
83
|
278
|
5j9tA |
Crystal structure of the nua4 core complex |
|
110
|
343
|
5kj2A |
The novel p300/cbp inhibitor a-485 uncovers a unique mechanism of action to target ar in castrate resistant prostate cancer |
|
77
|
292
|
5j9uA |
Crystal structure of the nua4 core complex |
|
70
|
272
|
5j8fA |
Human mof k274p crystal structure |
|
75
|
273
|
5j8cA |
Human mof c316s, e350q crystal structure |
|
41
|
117
|
5j0dA |
Crystal structure of the bromodomain of human crebbp in complex with a benzoxazepine compound |
|
56
|
234
|
5i8gA |
Cbp in complex with cpd637 ((r)-4-methyl-6-(1-methyl-3-(1-methyl-1h-pyrazol-4-yl)-1h-indazol-5-yl)-1,3,4,5-tetrahydro-2h-benzo[b][1,4]diazepin-2-one) |
|
54
|
139
|
5i29A |
Taf1(2) bound to a pyrrolopyridone compound |
|
62
|
234
|
5i8bA |
Cbp in complex with cpd23 ((r)-6-(3-(benzyloxy)phenyl)-4-methyl-1,3,4,5-tetrahydro-2h-benzo[b][1,4]diazepin-2-one) |
|
41
|
115
|
5i86A |
Crystal structure of the bromodomain of human crebbp bound to the benzodiazepinone g02778174 |
|
40
|
114
|
5i83A |
Crystal structure of the bromodomain of human crebbp bound to the benzodiazepinone g02773986 |
|
56
|
135
|
5i1qA |
Second bromodomain of taf1 bound to a pyrrolopyridone compound |
|
38
|
122
|
5hp0A |
Solution structure of taz2-p53ad2 |
|
48
|
158
|
5hpdA |
Solution structure of taz2-p53tad |
|
49
|
171
|
5houA |
Solution structure of p53tad-taz1 |
|
0
|
15
|
5h43C |
Structural and mechanistical studies of the nuclear import by importin-alpha |
|
1
|
10
|
5h43B |
Structural and mechanistical studies of the nuclear import by importin-alpha |
|
42
|
109
|
5fe7A |
Crystal structure of human pcaf bromodomain in complex with fragment zb2216 (fragment 11) |
|
40
|
108
|
5fe5A |
Crystal structure of human pcaf bromodomain in complex with fragment mb093 (fragment 7) |
|
39
|
108
|
5fe8A |
Crystal structure of human pcaf bromodomain in complex with compound sl1126 (compound 12) |
|
41
|
109
|
5fe9A |
Crystal structure of human pcaf bromodomain in complex with compound sl1122 (compound 13) |
|
39
|
107
|
5fe2A |
Crystal structure of human pcaf bromodomain in complex with fragment br013 (fragment 3) |
|
44
|
118
|
6frfA |
Crystal structure of crebbp bromodomain complexd with pa10 |
|
39
|
114
|
6fr0A |
Crystal structure of crebbp bromodomain complexd with pb08 |
|
2
|
9
|
6fo9B |
Vitamin d nuclear receptor complex 2 |
|
40
|
116
|
6fquA |
Crystal structure of crebbp bromodomain complexd with dr09 |
|
2
|
9
|
6fobB |
Vitamin d receptor complex 5 |
